glp-1 tracking software GLPer App Ranking the Best GLP-1 Apps:

We dont have much data yet and the Phase I so far was mixed, with Phase II data coming this year

Pivotal Phase 2 Trial Results The pivotal Phase 2 trial, published by Jastreboff and colleagues in the New England Journal of Medicine in August 2023, enrolled 338 adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity but without diabetes

They reduced their training volume without abandoning intensity

BW, body weight

It has been possible to map the incretin function in humans in some detail owing to the availability of receptor antagonists for both hormones, namely exendin 9-39 for the GLP-1 receptor and the amidated GIP fragment GIP 3-30 amide for the GIP receptor [2]

In other words, the liver benefits are not simply a downstream consequence of losing weight